Metelimumab

Tax included
Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that can selectively neutralize TGFβ1.
MedChemExpress 
HY-P99305

Data sheet

Size
Multiple sizes
Reactivity
TGF-β Receptor
Application
COVID-19-immunoregulation
CAS
272780-74-2